⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10883998 | 0.97 | — | — | |
| SCHEMBL11244367 | 0.75 | — | — | |
| SCHEMBL3161996 | 0.73 | — | — | |
| SCHEMBL11236391 | 0.73 | — | — | |
| Acetic Acid SCHEMBL28586564 | 0.73 | FFAR3 (0.47) | — | |
| SCHEMBL11423520 | 0.72 | — | — | |
| SCHEMBL1331568 | 0.71 | — | — | |
| SCHEMBL22613550 | 0.71 | — | — | |
| SCHEMBL11749869 | 0.71 | — | — | |
| Acetic Acid SCHEMBL27529054 | 0.71 | FFAR3 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118271567-A | Preparation method of hyperbranched modified poly (urethane-acrylic) resin and application of hyperbranched modified poly (urethane-acrylic) resin in cold-stamping connecting material | 江苏众立生包装科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| EP-0441480-B1 | Polychloroprene-based adhesive system | LORD CORP (US) | 1995-05-03 | — | — | EP | claimed |
| CN-118271567-A | Preparation method of hyperbranched modified poly (urethane-acrylic) resin and application of hyperbranched modified poly (urethane-acrylic) resin in cold-stamping connecting material | 江苏众立生包装科技有限公司 | 2024-07-02 | — | — | CN | disclosed |
| US-11807644-B2 | Methods and compounds for restoring mutant p53 function | PMV PHARMACEUTICALS, INC. (US) | 2023-11-07 | — | — | US | disclosed |
| CN-113214198-B | Compounds, compositions and methods for treating or preventing symptoms associated with gout or hyperuricemia | 广州瑞安博医药科技有限公司 | 2022-12-23 | — | — | CN | disclosed |
| EP-3831940-A1 | SMALL MOLECULE INHIBITORS OF CRISPR-CAS ASSOCIATED ACTIVITY | Danmarks Tekniske Universitet (DK) | 2021-06-09 | — | — | EP | disclosed |
| US-9371328-B2 | Imidazopyridazinecarbonitriles useful as kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-06-21 | — | — | US | disclosed |
| US-8389736-B2 | Compounds having activity in correcting mutant-CFTR processing and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-03-05 | — | — | US | disclosed |
| US-20120283241-A1 | IMIDAZOPYRIDAZINECARBONITRILES USEFUL AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2012-11-08 | — | — | US | disclosed |
| US-20120077787-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2012-03-29 | — | — | US | disclosed |
| US-20100273839-A1 | Compounds Having Activity in Correcting Mutant-CFTR Processing and Uses Thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2010-10-28 | — | — | US | disclosed |
| WO-2009051909-A1 | COMPOUNDS HAVING ACTIVITY IN CORRECTING MUTANT-CFTR CELLULAR PROCESSING AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-04-23 | — | — | WO | disclosed |
| US-7329651-B2 | Cannabimimetic ligands | UNIVERSITY OF CONNECTICUT (US) | 2008-02-12 | — | — | US | disclosed |
| US-7214715-B2 | Compounds to treat Alzheimer's disease | PHARMACIA & UPJOHN (US) | 2007-05-08 | — | — | US | disclosed |
| US-6900258-B2 | High solids emulsions of curable elastomeric polymers | DOW CORNING CORPORATION (US) | 2005-05-31 | — | — | US | disclosed |